TAF3 (C-term), 606-635 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-TAF3 (C-term), 606-635 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TAF3 (C-term), 606-635 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This TAF3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 606-635 amino acids from the C-terminal region of human TAF3. The highly conserved RNA polymerase II transcription factor TFIID (see TAF1; MIM 313650) comprises the TATA box-binding protein (TBP; MIM 600075) and a set of TBP-associated factors (TAFs), including TAF3. TAFs contribute to promoter recognition and selectivity and act as antiapoptotic factors (Gangloff et al., 2001 [PubMed 11438666]). |
| Immunogen | n/a |
| Other Names | [Transcription initiation factor TFIID subunit 3; 140 kDa TATA box-binding protein-associated factor; TBP-associated factor 3; Transcription initiation factor TFIID 140 kDa subunit; TAF(II)140; TAF140; TAFII-140; TAFII140; TAF3] |
| Gene, Accession # | [TAF3], Gene ID: 83860, NCBI: NP_114129.1, UniProt: Q5VWG9 |
| Catalog # | MBS9214461 |
| Price | $165, $370 |
| Order / More Info | TAF3 (C-term), 606-635 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Trynka, G., et al. Gut 58(8):1078-1083(2009) Luke, M.M., et al. Stroke 40(2):363-368(2009) Shiffman, D., et al. Arterioscler. Thromb. Vasc. Biol. 28(1):173-179(2008) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies